Cell No. : Cell Name
RCB0016 : CCRF-HSB-2
update : 2024/11/19
|
| Comment | T cell leukemia |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Todokoro, Kazuo
|
| Originator |
G.E. Foley et al.
|
| Year of deposit |
1986
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Gender |
Male
|
| Tissue |
blood
|
| Disease name |
T-cell leukemia
|
| Classification |
cancer
|
| Year of origin |
1966
|
| History |
JCRB
|
|
Lifespan |
infinite
|
| Morphology |
lymphoblast-like
|
| Cellosaurus(Expasy) |
CVCL_1859
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Suspension cells
|
| Culture method |
|
浮遊細胞の培養に関する一般的な注意(Japanese)
|
| Culture medium |
|
RPMI1640 + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
dilution
|
Culture information
|
Passage ratio |
|
1 : 10 split
|
| SC frequency |
|
Subculture : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| Virus (HIV) |
|
(-)
|
| Virus (HTLV-1) |
|
(-)
|
| Isozyme |
|
LD, NP
|
| Chromosome mode |
|
45-92(50) : 45(3),46(42),47(4),92(1)
|
| STR(human) |
|
OK
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
3
|
| User's Publication |
5
|
| Reference |
|
5042
Haruta Y, Seon BK.
Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.
Proc Natl Acad Sci U S A
1986
83(20):7898-902
PubMed ID: 3464004
DOI: 10.1073/pnas.83.20.7898
|
|
86
Adams RA, Pothier L, Flowers A, Lazarus H, Farber S, Foley GE.
The question of stemlines in human acute leukemia. Comparison of cells isolated in vitro and in vivo from a patient with acute lymphoblastic leukemia
Exp Cell Res
1970
62(1):5-10
PubMed ID: 4991454
DOI: 10.1016/0014-4827(79)90504-4
|
|
4601
Adams RA, Flowers A, Davis BJ.
Direct implantation and serial transplantation of human acute lymphoblastic leukemia in hamsters, SB-2.
Cancer Res
1968
28(6):1121-5.
PubMed ID: 4872716
|
| User's Publication |
|
16817
Kasahara Y, Shin C, Kubo N, Mihara K, Iwabuchi H, Takachi T, Imamura M, Saitoh A, Imai C.
Development and characterisation of NKp44-based chimeric antigen receptors that confer T cells with NK cell-like specificity
Clin Transl Immunology
2020
9(7):e1147
PubMed ID: 32670576
DOI: 10.1002/cti2.1147
|
|
15551
Hirohisa Matsushita, Hiroaki Kuwabara, Satoko Ishikawa, Masataka Mochizuki
Apoptosis Induced in Human Cell Lines by a Butanol Extract from Chlorophytum comosum Roots
Journal of Health Science
2005
51:341-345
DOI: 10.1248/jhs.51.341
|
|
2643
Williams YN, Baba H, Hayashi S, Ikai H, Sugita T, Tanaka S, Miyasaka N, Kubota T.
Dipeptidyl peptidase IV on activated T cells as a target molecule for therapy of rheumatoid arthritis.
Clin. Exp. Immunol.
2003
131:68-74
PubMed ID: 12519388
DOI: 10.1046/j.1365-2249.2003.02020.x
|
|
5423
Tanaka K, Hiramoto T, Fukuda T, Miyagawa K.
A novel human rad54 homologue, Rad54B, associates with Rad51.
J Biol Chem
2000
275(34):26316-21
PubMed ID: 10851248
DOI: 10.1074/jbc.M910306199
|
|
2747
Kawaii S, Tomono Y, Katase E, Ogawa K, Yano M, Takemura Y, Ju-ichi M, Ito C, Furukawa H.
The antiproliferative effect of acridone alkaloids on several cancer cell lines
J Nat Prod
1999
62(4):587-9
PubMed ID: 10217715
DOI: 10.1021/np980504z
|
Back
Top
CELL BANK Website